Distribution Agreement Signed for Assistant Digital Cell Imaging System
By LabMedica International staff writers Posted on 19 May 2014 |
Image: Medica EasyCell assistant (Photo courtesy of Medica Corporation).
HORIBA Medical (Montpellier, France) and Medica Corporation (Bedford, MA, USA) have entered into a nonexclusive agreement for the worldwide distribution of the EasyCell assistant digital hematology cell imaging system for use in hospitals and clinical laboratories worldwide.
The EasyCell assistant automatically locates white cells on a blood smear and preclassifies them on a display, grouped by cell type. The system displays images of red cells and platelets for performance of red cell morphology and platelet estimates. The EasyCell also features Remote Viewing Software for sharing of cell images throughout the hospital and Competency Review Software for training of medical technologists in the hematology laboratory.
Olivier Pou, corporate marketing director, HORIBA Medical commented on the agreement with the Medica Corp., "The EasyCell assistant is an important addition to our hematology product range and is a good match with our five-part differential hematology instrument portfolio. The addition of the Medica EasyCell assistant to our product offering makes it possible for HORIBA Medical to provide a complete range of advanced technology to our hematology customers, worldwide."
Medica Corp. uses its proprietary technology to manufacture easy-to-use, low-cost, blood testing analyzers. The analyzers are easy to operate and service and can be used routinely by personnel with a wide range of skill levels in hospital laboratories.
HORIBA Medical provides an extensive and complete line of hematology and clinical chemistry analyzers (including reagents) for in vitro medical diagnostics.
Related Links:
HORIBA Medical
Medica Corporation
The EasyCell assistant automatically locates white cells on a blood smear and preclassifies them on a display, grouped by cell type. The system displays images of red cells and platelets for performance of red cell morphology and platelet estimates. The EasyCell also features Remote Viewing Software for sharing of cell images throughout the hospital and Competency Review Software for training of medical technologists in the hematology laboratory.
Olivier Pou, corporate marketing director, HORIBA Medical commented on the agreement with the Medica Corp., "The EasyCell assistant is an important addition to our hematology product range and is a good match with our five-part differential hematology instrument portfolio. The addition of the Medica EasyCell assistant to our product offering makes it possible for HORIBA Medical to provide a complete range of advanced technology to our hematology customers, worldwide."
Medica Corp. uses its proprietary technology to manufacture easy-to-use, low-cost, blood testing analyzers. The analyzers are easy to operate and service and can be used routinely by personnel with a wide range of skill levels in hospital laboratories.
HORIBA Medical provides an extensive and complete line of hematology and clinical chemistry analyzers (including reagents) for in vitro medical diagnostics.
Related Links:
HORIBA Medical
Medica Corporation
Latest Industry News
- Danaher and Johns Hopkins University Collaborate to Improve Neurological Diagnosis
- Beckman Coulter and MeMed Expand Host Immune Response Diagnostics Partnership
- Thermo Fisher and Bio-Techne Enter Into Strategic Distribution Agreement for Europe
- ECCMID Congress Name Changes to ESCMID Global
- Bosch and Randox Partner to Make Strategic Investment in Vivalytic Analysis Platform
- Siemens to Close Fast Track Diagnostics Business
- Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics
- Sysmex and Hitachi Collaborate on Development of New Genetic Testing Systems
- Sysmex and CellaVision Expand Collaboration to Advance Hematology Solutions
- BD and Techcyte Collaborate on AI-Based Digital Cervical Cytology System for Pap Testing
- Medlab Middle East 2024 to Address Transformative Potential of Artificial Intelligence
- Seegene and Microsoft Collaborate to Realize a World Free from All Diseases and Future Pandemics
- Medlab Middle East 2024 to Highlight Importance of Sustainability in Laboratories
- Fujirebio and Agappe Collaborate on CLIA-Based Immunoassay
- Medlab Middle East 2024 to Highlight Groundbreaking NextGen Medicine
- bioMérieux Acquires Software Company LUMED to Support Fight against Antimicrobial Resistance